Navigation Links
New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia

Findings indicate early non-responders unlikely to subsequently respond, have substantially more treatment costs, and may benefit from earlier change in treatment strategy

COLORADO SPRINGS, Colo., April 03, 2007 /PRNewswire-FirstCall/ -- New data presented at the 2007 International Congress on Schizophrenia Research (ICOSR) suggest that antipsychotic drug response be assessed earlier than is presently thought, and challenge the current schizophrenia treatment paradigm for when to evaluate if an antipsychotic medication is working effectively.

The findings show that early non-response to antipsychotic medication, as early as two weeks into treatment, appears to strongly predict subsequent lack of response in patients with schizophrenia. Compared to "early responders" - patients who responded to their antipsychotic medication after two weeks of treatment - the "early non-responders" were less likely to achieve subsequent symptom remission, viewed medication adherence as less beneficial, had a lower level of functioning, and incurred twice as many total healthcare costs. The studies were conducted and funded by Eli Lilly and Company.

Early non-response may be a powerful marker to not only predict prognosis in schizophrenia, but also tailor appropriate treatment to the patient's immediate needs. These data support the need for clinicians' early evaluation of patients' treatment response, and the possible need for a change in the medication to potentially help minimize prolonging exposure to sub-optimal or ineffective treatment.

Current schizophrenia treatment guidelines recommend an initial trial of four to six weeks to determine if a patient will respond to an antipsychotic medication(i). However, these new data suggest this may be too long. Without early and effective treatment, patients with schizophrenia may experience devastating and costly events, such as hospitalization(ii), incarceratio
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
3. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
4. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
5. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
6. Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data
7. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
8. Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
9. Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron
10. Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability
11. First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability
Post Your Comments:
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... Aug. 21, 2014  SI-BONE, Inc. ( San ... pioneered the use of the iFuse Implant System, ® ... fusion of the sacroiliac (SI) joint, announced that Priority ... to its Lumbar Fusion Medical Policy No. 91590-R4 providing ... The policy states that the fusion procedure, which employs ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kentucky blocked the sale of ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... MISSISSAUGA, Ontario, March 11, 2011 Valeant Pharmaceuticals ... VRX) announced that effective March 10, 2011, the ... S.A. About Valeant Valeant Pharmaceuticals ... pharmaceutical company that develops, manufactures and markets a ...
... (Nasdaq: OPTR ) today announced 2010 fourth quarter ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO ) Optimer reported a ... of $11.9 million, or $0.31 per common share, as compared ... common share, for the same period in 2009.  Optimer reported ...
Cached Medicine Technology:Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 2Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 3Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 4Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 5Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 6Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 7Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 8
(Date:8/21/2014)... 21, 2014 The results of a ... The Journal of the American Medical Association (JAMA) show ... and reduces unnecessary recalls. Memorial Healthcare System was one ... , “This study confirms what we already know – ... we want to find and, at the same time, ...
(Date:8/21/2014)... 2014 The report "Industrial Flue ... Control System (FGD, DeNOx, Particulate Control, Mercury Control) ... Chemical & Others) - Global Trends & Forecasts ... flue gas treatment systems & services market with ... in terms of value. The industrial flue gas ...
(Date:8/21/2014)... Lauren Collura, a mother of two from ... the Boardwalk” Facebook sweepstakes. Lauren, her husband, and two children ... house in Lavallette beginning this Saturday. , This is ... Last year, Horizon Blue Cross Blue Shield of New Jersey ... and decided to make it a new summer tradition. ...
(Date:8/21/2014)... American Addiction Centers, a leading national provider of inpatient ... alcohol addiction, has been named to the Inc. 500 ... company is ranked 7th on the “Top 20 Tennessee ... list in the “Nashville Metro Area” sub-category. With a ... (AAC) ascended to number 474 on the larger list ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Using two types ... the disease and may boost efforts to eradicate polio, ... 1,000 children in India found that giving the Salk ... been given the Sabin live-attenuated oral poliovirus vaccine (OPV) ... causes polio. The findings, reported in the Aug. ...
Breaking Medicine News(10 mins):Health News:Dr. Mary Hayes: Study Shows 3D Mammography Finds More Invasive Cancers While Reducing Unnecessary Recalls 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 3Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 4Health News:American Addiction Centers Named to Inc. 500 List Recognition for Three-Year Sales Growth of 995% 2Health News:Two Polio Vaccines May Give Greater Protection Against Crippling Disease 2
... for the AACR 102nd Annual Meeting 2011 is Friday, Feb. ... for editors and reporters, and we cannot guarantee that housing ... meeting will feature the latest findings in laboratory, translation and ... the meeting, including: nicotine supplements and tumor ...
... that infection with human immunodeficiency virus (HIV) impaired ... more HIV infected patients dropping off the transplantation ... and recurrence-free survival was not impacted following liver ... of this single center studythe largest to dateare ...
... used by caterpillars that transform into large white butterflies, ... leaves to make them smell and taste unpleasant to ... of this defence reduces the caterpillars, growth rate and ... unclear why their defences affect them in this way, ...
... Reinberg HealthDay Reporter , MONDAY, Jan. 24 ... cognitive behavioral therapy may reduce the risk of heart ... researchers report. About 30 percent of heart attacks may ... poverty or emotional problems, such as depression and hostility, the ...
... have saved $77 million in 2006 if it ... cardiovascular drugs angiotensin receptor blockers without a negative ... published in CMAJ (Canadian Medical Association Journal) (pre-embargo ... costs in Canada increased by more than 200% ...
... Reporter , MONDAY, Jan. 24 (HealthDay News) -- Doctors ... pain report that they discovered the treatment consistently lowered ... introduces the possibility that deep brain stimulation -- ... brain -- might one day become a treatment for ...
Cached Medicine News:Health News:The American Association for Cancer Research hosts its 102nd Annual Meeting 2Health News:Patients infected with HIV have higher drop-out rate for liver transplantation 2Health News:Insects that deter predators produce fewer offspring 2Health News:Stress-Reduction Therapy May Help Heart Disease Patients 2Health News:Stress-Reduction Therapy May Help Heart Disease Patients 3Health News:Controlling the rising costs of cardiovascular care 2Health News:Deep Brain Stimulation Might Ease Tough-to-Treat Hypertension 2
Albarran double-horn bridge for use with sheaths from 20-25 Fr and designed for accurate articulation of flexible devices....
... and removal in the urinary tract. The nitinol ... shape following extreme torsion. The unique tipless design ... basket to open at the base of the ... reduces the likelihood of mucosal damage and perforation. ...
Bard Coude-Tip Latex Urethral Catheter, Two Eyes (Tiemann Model)...
Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
Medicine Products: